Clinical Trials

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

2,700 enrolled

Breast Neoplasms, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT03425565 2024-04-12

PEACOCC

48 enrolled

Clear Cell Tumor

NCT06308406 2024-04-11

A Phase Ib/II Clinical Study of HRS-1167 in Combination With Bevacizumab in Patients With Recurrent Ovarian Cancer

Phase 1/2 Unknown

54 enrolled

Ovarian Neoplasms

NCT06351228 2024-04-08

Eternity

400 enrolled

Uterine Cervical Neoplasms

NCT06341855 2024-04-02

Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer

Endometrial Neoplasms

NCT05311618 2024-04-01

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

71 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT04929015 2024-03-21

Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)

30 enrolled

Digestive System Neoplasms, Carcinoma, Hepatocellular, Peritoneal Neoplasms

NCT05305820 2024-03-21

PANO

36 enrolled

Appendiceal Neoplasms, Colonic Neoplasms, Ovarian Neoplasms, Rectal Neoplasms

NCT06320418 2024-03-20

The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression

56 enrolled

Ovarian Neoplasms

NCT06317610 2024-03-19

Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids

Ovarian Neoplasms

NCT06242522 2024-03-15

FERTILAVE

50 enrolled

Gestational Trophoblastic Tumours

NCT05368207 2024-03-13

Pemb-HT

1 enrolled

Ovarian Neoplasms, Carcinoma, Small Cell

NCT06304922 2024-03-12

BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary

45 enrolled

Ovarian Neoplasms

NCT06294886 2024-03-07

Vaginal Fluid Collection for Detection of Endometrial Cancer

40 enrolled

Endometrial Neoplasms

NCT04766320 2024-03-06

Study on TIL for the Treatment of r/r Gynecologic Tumors

15 enrolled

Gynecologic Cancer

NCT04780217 2024-03-04

Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors

Phase 1/2 Unknown

42 enrolled

Carcinoma, Hepatocellular, Ovarian Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT06284980 2024-02-29

TITANIUM

120 enrolled

Gestational Trophoblastic Disease

NCT04512209 2024-02-28

DCE-MRI

44 enrolled

Colonic Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms

NCT06031493 2024-02-28

PROVIDENCE

Phase 4 Unknown

122 enrolled

GynecologicOther

Uterine Cervical Neoplasms, Sexual Dysfunction, Physiological

NCT06279832 2024-02-28

Romantic

1,000 enrolled

Endometrial Neoplasms

NCT06281860 2024-02-28

PITHAC

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

39 enrolled

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT05371223 2024-02-26

Nab-PIPAC

38 enrolled

Pancreatic Neoplasms, Peritoneal Neoplasms

NCT06277947 2024-02-26

GARD-HIPEC

92 enrolled

Carcinoma, Ovarian Epithelial

NCT06278636 2024-02-26

LUXA

Gynecologic Cancer

NCT05701735 2024-02-23

CECIL

45 enrolled

Uterine Cervical Neoplasms, Renal Insufficiency

NCT05728814 2024-02-23

DORA

Endometrial Neoplasms

NCT06124040 2024-02-23

SUCCEEDER

154 enrolled

Uterine Cervical Neoplasms

NCT06273878 2024-02-23

From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy

80 enrolled

Endometrial Neoplasms

NCT05300711 2024-02-22

Preventing Ovarian Cancer Through Oportunistic Salpingectomy at the Time of Colorectal Surgery

240 enrolled

Ovarian Neoplasms

NCT05737797 2024-02-22

NIECE

Endometrial Neoplasms, Microsatellite Instability

NCT06273501 2024-02-22

POSVUC

20 enrolled

Lymphatic Metastasis, Vulvar Neoplasms

NCT03924466 2024-02-16

VUBAR

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

55 enrolled

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT06263062 2024-02-16

Management With Fear of Cancer in Women Undergoing Colposcopy: Randomized Controlled Study

60 enrolled

Pathophobia, Uterine Cervical Neoplasms

NCT06261879 2024-02-15

Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood

Uterine Cervical Neoplasms

NCT06261892 2024-02-15

Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer-HPV DNA and Other Biomarkers in Urine

Uterine Cervical Neoplasms

NCT04145388 2024-02-14

Family History Study on Cancer Risk

BreastGastrointestinalGynecologic

18,623 enrolled

Breast Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms, Genetic Predisposition to Disease

NCT02730923 2024-02-13

VICTORIA

Phase 1/2 Unknown

72 enrolled

Carcinoma, Endometrial Neoplasms

NCT05829057 2024-02-13

The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1

GastrointestinalGenitourinaryGynecologicThoracic

10 enrolled

Urinary Bladder Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Small Cell Lung Carcinoma

NCT06250686 2024-02-09

BENITA

185 enrolled

Fatigue, Muscular Atrophy, Ovarian Neoplasms, Malnutrition

NCT02820506 2024-02-08

SENTIREC II

Uterine Cervical Neoplasms, Uterine Neoplasms

NCT03549273 2024-02-07

Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial Lesions

62 enrolled

Carcinoma, Uterine Cervical Dysplasia, Neoplasms, Neoplasms, Glandular and Epithelial

NCT04149691 2024-02-07

Safety, Tolerability and Pharmacokinetics of Oral CPL304110, in Adult Subjects With Advanced Solid Malignancies

GastrointestinalGenitourinaryGynecologicSarcoma

42 enrolled

Urinary Bladder Neoplasms, Carcinoma, Neoplasms, Sarcoma, Stomach Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma

NCT05916911 2024-02-07

Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)

Phase 4 Unknown

120 enrolled

Squamous Intraepithelial Lesions, Papillomavirus Infections

NCT06069648 2024-02-07

Effects of Decision Aids on the Participation of South Asian Women in Cervical Cancer Screening

270 enrolled

Uterine Cervical Neoplasms

NCT05189028 2024-02-06

Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer

Phase 3 Unknown

290 enrolled